Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Myeloperoxidase Deficiency Alters the Process of the Regulated Cell Death of Polymorphonuclear Neutrophils

S. Kremserová, A. Kocurková, M. Chorvátová, A. Klinke, L. Kubala

. 2022 ; 13 (-) : 707085. [pub] 20220208

Language English Country Switzerland

Document type Journal Article, Research Support, Non-U.S. Gov't

Polymorphonuclear neutrophils (PMNs) play a key role in host defense. However, their massive accumulation at the site of inflammation can delay regenerative healing processes and can initiate pathological inflammatory processes. Thus, the efficient clearance of PMNs mediated by the induction of regulated cell death is a key process preventing the development of these pathological conditions. Myeloperoxidase (MPO), a highly abundant enzyme in PMN granules, primarily connected with PMN defense machinery, is suggested to play a role in PMN-regulated cell death. However, the contribution of MPO to the mechanisms of PMN cell death remains incompletely characterized. Herein, the process of the cell death of mouse PMNs induced by three different stimuli - phorbol 12-myristate 13-acetate (PMA), opsonized streptococcus (OST), and N-formyl-met-leu-phe (fMLP) - was investigated. MPO-deficient PMNs revealed a significantly decreased rate of cell death characterized by phosphatidylserine surface exposure and cell membrane permeabilization. An inhibitor of MPO activity, 4-aminobenzoic acid hydrazide, did not exhibit a significant effect on PMA-induced cell death compared to MPO deficiency. Interestingly, only the limited activation of markers related to apoptotic cell death was observed (e.g. caspase 8 activation, Bax expression) and they mostly did not correspond to phosphatidylserine surface exposure. Furthermore, a marker characterizing autophagy, cleavage of LC3 protein, as well as histone H3 citrullination and its surface expression was observed. Collectively, the data show the ability of MPO to modulate the life span of PMNs primarily through the potentiation of cell membrane permeabilization and phosphatidylserine surface exposure.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22011044
003      
CZ-PrNML
005      
20220506131113.0
007      
ta
008      
220425s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2022.707085 $2 doi
035    __
$a (PubMed)35211113
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Kremserová, Silvie $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czechia
245    10
$a Myeloperoxidase Deficiency Alters the Process of the Regulated Cell Death of Polymorphonuclear Neutrophils / $c S. Kremserová, A. Kocurková, M. Chorvátová, A. Klinke, L. Kubala
520    9_
$a Polymorphonuclear neutrophils (PMNs) play a key role in host defense. However, their massive accumulation at the site of inflammation can delay regenerative healing processes and can initiate pathological inflammatory processes. Thus, the efficient clearance of PMNs mediated by the induction of regulated cell death is a key process preventing the development of these pathological conditions. Myeloperoxidase (MPO), a highly abundant enzyme in PMN granules, primarily connected with PMN defense machinery, is suggested to play a role in PMN-regulated cell death. However, the contribution of MPO to the mechanisms of PMN cell death remains incompletely characterized. Herein, the process of the cell death of mouse PMNs induced by three different stimuli - phorbol 12-myristate 13-acetate (PMA), opsonized streptococcus (OST), and N-formyl-met-leu-phe (fMLP) - was investigated. MPO-deficient PMNs revealed a significantly decreased rate of cell death characterized by phosphatidylserine surface exposure and cell membrane permeabilization. An inhibitor of MPO activity, 4-aminobenzoic acid hydrazide, did not exhibit a significant effect on PMA-induced cell death compared to MPO deficiency. Interestingly, only the limited activation of markers related to apoptotic cell death was observed (e.g. caspase 8 activation, Bax expression) and they mostly did not correspond to phosphatidylserine surface exposure. Furthermore, a marker characterizing autophagy, cleavage of LC3 protein, as well as histone H3 citrullination and its surface expression was observed. Collectively, the data show the ability of MPO to modulate the life span of PMNs primarily through the potentiation of cell membrane permeabilization and phosphatidylserine surface exposure.
650    _2
$a zvířata $7 D000818
650    _2
$a zánět $x metabolismus $7 D007249
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a neutrofily $x metabolismus $x patologie $7 D009504
650    _2
$a peroxidasa $x nedostatek $x metabolismus $7 D009195
650    _2
$a regulovaná buněčná smrt $7 D000079404
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kocurková, Anna $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czechia $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia
700    1_
$a Chorvátová, Michaela $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czechia $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia
700    1_
$a Klinke, Anna $u Clinic of General and Interventional Cardiology/Angiology, Agnes Wittenborg Institute of Translational Cardiovascular Research, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany
700    1_
$a Kubala, Lukáš $u Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno, Czechia $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czechia $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 13, č. - (2022), s. 707085
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35211113 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506131106 $b ABA008
999    __
$a ok $b bmc $g 1788905 $s 1162242
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 13 $c - $d 707085 $e 20220208 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20220425

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...